FORUM VIDEOS

 

ROUNDTABLE IA

Funding Innovation
New Trends in the Healthcare M&A Landscape
(Co-sponsored by Biopharm Insight, part of the Financial Times Group and by Proskauer)

Kimberly Ha Hunt Henrie Paul I. Rachlin Les Funtleyder Jonathan Silverstein Jide Zeitlan
Kimberly Ha, Global Editor, Biopharm Insight Hunt Henrie Paul I. Rachlin, Partner, Proskauer Les Funtleyder, MPH, Healthcare Strategist and Portfolio Manager, Miller Tabak Health Care Transformation Fund Jonathan Silverstein, Partner, OrbiMed Advisors Jide Zeitlan, CEO, Keffi Group

Part 1: Kimberly Ha
Part 2: Kimberly Ha, Hunt Henrie and Paul I. Rachlin
Part 3: Kimberly Ha, Hunt Henrie, Paul I. Rachlin and Les Funtleyder
Part 4: Kimberly Ha and Les Funtleyder
Part 5: Kimberly Ha, Jonathan Silverstein, Hunt Henrie, Paul I. Rachlin and Les Funtleyder
Part 6: Kimberly Ha, Jonathan Silverstein, Jide Zeitlan, Paul I. Rachlin, Les Funtleyder and Hunt Henrie
Part 7: Kimberly Ha and Hunt Henrie
Part 8: Kimberly Ha, Paul I. Rachlin, Jonathan Silverstein, Hunt Henrie, Jide Zeitlan, and Les Funtleyder
Part 9: Kimberly Ha, Jonathan Silverstein, Hunt Henrie, Paul I. Rachlin and Les Funtleyder
Part 10: Kimberly Ha, Jonathan Silverstein and Jide Zeitlan
Part 11: Hunt Henrie, Jonathan Silverstein, Paul I. Rachlin and Jide Zeitlan
Part 12: Les Funtleyder, Paul I. Rachlin, Jonathan Silverstein, and Hunt Henrie

ROUNDTABLE IB

What is "Value" and How Can it be Measured and Demonstrated in Therapeutic Innovations?
Breaking Down the Barriers of the Past

Richard C. Pasternak Peter J. Pitts Roger Longman Jeffery Berkowitz Barry Gertz Robert S. Epstein
Richard C. Pasternak, MD, former Merck & Co., Inc vice president. and past director, Preventive Cardiology Massachusetts General Hospital and Harvard Medical School associate professor Peter J. Pitts, President, Center for Medicine in the Public Interest Roger Longman, CEO, Real Endpoints Jeffery Berkowitz, SVP Pharmaceutical Development and Market Access at Walgreens Barry Gertz, MD, PhD., SVP at Merck, and head of clinical research and regulatory affairs Robert S. Epstein M.D., Chief Clinical Research and Development Officer, Medco Health Solutions, Inc.

Part 1: Richard C. Pasternak, Peter J. Pitts, Roger Longman, Jeffery Berkowitz, Barry Gertz and Robert S. Epstein
Part 2: Peter J. Pitts
Part 3: Barry Gertz
Part 4: Robert S. Epstein
Part 5: Roger Longman
Part 6: Jeffery Berkowitz
Part 7: Peter J. Pitts
Part 8: Barry Gertz
Part 9: Discussion

ROUNDTABLE IIA

The Next Generation of Health and Research Informatics
Accelerating Translational Research & Personalized Medicine at Moffitt Cancer Center
(Sponsored by Oracle)

Brett Davis Robert M. Wenham Dana Rollison Mark Hulse
Brett Davis, Senior Director, Personalized Healthcare, Oracle Corporation, Health Sciences Global Business Unit Robert M. Wenham, MD, MS, FACOG, FACS, Principal Investigator, Total Cancer Care Programs of Gynecologic Oncology & Experimental Therapeutics Moffitt
Cancer Center
Dana Rollison, Ph.D., Vice President, Total Cancer Care and Chief Health Information Officer, Moffitt Cancer Center Mark Hulse, RN, Vice President Information Technology and Chief Information Officer, Moffitt Cancer Center and Dana Rollison

Part 1: Brett Davis
Part 2: Robert M. Wenham
Part 3: Dana Rollison
Part 4: Mark Hulse and Dana Rollison
Part 5: Brett Davis, Mark Hulse, Dana Rollison and Robert M. Wenham

ROUNDTABLE IIB

A Global Health Challenge: The Obesity and Diabetes Epidemic
Where are the Innovations and Who Will Pay For Them?
(Sponsored by Alexandria Real Estate Equities, Inc.)

Lynne Zydowsky Ron Winslow Francesco Rubino Stephen Daniels
Lynne Zydowsky, PhD, President, Zydowsky Consultants Ron Winslow, Senior Medical and Health Care Writer, WSJ Deputy Editor, Health and Science Francesco Rubino, MD, Associate Professor of Surgery, Director, Metabolic & Diabetes Surgery Center, Weill Cornell Medical College Stephen Daniels, MD, PhD, MPH, Professor and Chair, Department of Pediatrics, University of Colorado School of Medicine, Pediatrician-in-Chief , L Joseph, Butterfield Chair in Pediatrics, Children's Hospital Colorado
Martin Fitchet Magnus Persson Alex DePaoli Jeffrey Friedman
Martin Fitchet, MD, Chief Operating Officer, Johnson & Johnson, Pharmaceutical Research & Development Magnus Persson, MD, PhD, Managing Partner, The Column Group Alex DePaoli, MD, Vice President of Translational Research, NGM Biopharmaceuticals Jeffrey Friedman, MD, PhD, Marilyn M Simpson Professor, Investigator Howard Hughes Medical Institute, Laboratory of Genetics, The Rockefeller University

Part 1: Lynne Zydowsky
Part 2: Ron Winslow
Part 3: Francesco Rubino
Part 4: Stephen Daniels
Part 5: Martin Fitchet
Part 6: Magnus Persson
Part 7: Alex DePaoli
Part 8: Jeffrey Friedman
Part 9: Discussion

ROUNDTABLE IIC

Perspectives on Innovation, Patient Safety and Global Access
Thinking Beyond Laboratories and Clinical Trials

Michael Rosenblatt Larry Norton Peter D. Loftus Steven Nissen Mark Pykett Kevin Tabb
Michael Rosenblatt, MD, Executive Vice President and Chief Medical Officer, Merck & Co., Inc. Larry Norton, MD, Deputy physician-in-chief for breast cancer programs and medical director, Evelyn H. Lauder Breast Center, Memorial Sloan-Kettering Cancer Center Peter D. Loftus, Dow Jones Newswires reporter covering pharmaceutical industry; contributor to Wall Street Journal Steven Nissen, M.D., M.A.C.C., Chairman, Department of Cardiovascular Medicine Cleveland Clinic Foundation and Professor of Medicine, Cleveland Clinic Lerner School of Medicine at Case Western Reserve U. Mark Pykett, President and Chief Executive Officer, Neoprobe Corporation Kevin Tabb, MD, chief medical officer, Stanford Hospital & Clinics.

Part 1: Michael Rosenblatt
Part 2: Larry Norton
Part 3: Peter D. Loftus
Part 4: Steven Nissen
Part 5: Mark Pykett
Part 6: Kevin Tabb
Part 7: Michael Rosenblatt, Peter D. Loftus, Steven Nissen, Larry Norton, Mark Pykett and Kevin Tabb